With Johnson & Johnson bowing out of the diabetes device market, US firm CeQur has benefited from this exit by securing assets from the health-care giant's Calibra Medical insulin delivery device business.
CeQur, a 10-year old company, has acquired selected assets of J&J's Calibra's OneTouch Via product – a three-day, wearable, on-demand...






